Viewing Study NCT04969068


Ignite Creation Date: 2025-12-24 @ 5:55 PM
Ignite Modification Date: 2025-12-29 @ 3:23 PM
Study NCT ID: NCT04969068
Status: UNKNOWN
Last Update Posted: 2022-01-10
First Post: 2021-07-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Median Effective Dose of Remimazolam for Duodenoscopy Insertion During ERCP With Alfentanil 10µg/kg
Sponsor: Tianjin Nankai Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Anesthesia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None remimazolam View
None alfentanil View
None duodenoscopy insertion View
None ERCP View